Orchid Chemicals & Pharmaceuticals Ltd
Unaudited Financial Results for nine months ended December 31, 2004
           
(Rs.Lakhs)
Sl No Particulars
Three months ended
December 31, 2004
(Unaudited)
Three months ended
December 31, 2003
(Unaudited)
Nine months ended
December 31, 2004
(Unaudited)
Nine months ended
December 31, 2003
(Unaudited)
Year ended March 31, 2004
(Audited)
1
 Sales and Operating Income
17225.78
17286.09
50989.47
51176.37
71340.98
2
 Other Income
93.02
39.13
192.88
103.71
123.12
3
 Total Expenditure
13095.19
13642.90
39024.29
40344.75
56415.00
a) Decrease/(Increase) in Stock in trade
(3538.13)
(424.56)
(4362.80)
(3586.39)
(4387.75)
b) Consumption of raw materials
10675.07
8393.34
26970.13
28265.87
39355.45
c) Staff Cost
1549.75
1183.16
4096.85
3345.67
4841.60
d) Other Expenditure
4408.50
4490.96
12320.11
12319.60
16605.70
4
Profit before Interest, Depreciation & Tax (1+2-3)
4223.61
3682.32
12158.06
10935.33
15049.10
5
 Interest and Finance Charges
1792.11
1642.09
5372.57
4411.67
6067.08
6
 Depreciation
1556.39
1288.21
4635.50
4053.08
5684.23
7
 Profit before tax (4-5-6)
875.11
752.02
2149.99
2470.58
3297.79
8
 Provision for Taxation
      Current Tax
37.80
43.04
137.77
143.10
195.00
      Deferred Tax
261.13
(131.60)
570.81
-
9
 Net Profit (7-8)
576.18
840.58
1441.41
2327.48
3102.79
10
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
3238.19
3238.19
3238.19
3238.19
3238.19
11
 Reserves excluding Revaluation Reserves
38630.88
12
 Basic Earnings per Share (Rs.)
1.78*
2.60*
4.45*
7.19*
9.58
13 Diluted Earnings per Share (Rs.)
1.68*
2.60*
4.21*
7.19*
9.58
 
   
 
SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
(Rs.Lakhs)
Particulars

Three months ended
December 31, 2004
Three months ended
December 31, 2003
Nine months ended
December 31, 2004
Nine months ended
December 31, 2003
Year ended March 31, 2004
1. Segment Revenue        
a. Bulk
15046.00
15180.30
44184.90
44809.28
62455.23
b. Formulations
2195.40
2331.12
7147.42
7915.93
10441.13
Total
17241.40
17511.42
51332.32
52725.21
72896.36
Less: Inter segment revenue
15.62
225.33
342.85
1548.84
1555.38
Net Sales / Income from Operations
17225.78
17286.09
50989.47
51176.37
71340.98
 
 
2. Segment Results:
a. Bulk
2908.18
2305.11
7689.74
6517.09
9546.72
b. Formulations
(333.98)
49.87
(360.06)
261.45
(128.57)
Total
2574.20
2354.98
7329.68
6778.54
9418.15
 
Less: i) Interest (Net)
1792.11
1642.09
5372.57
4411.67
6067.08
ii) Other unallocable expenditure net of unallocable income
(93.02)
(39.13)
(192.88)
(103.71)
53.28
Total Profit Before Tax
875.11
752.02
2149.99
2470.58
3297.79
 
3. Capital Employed
a. Bulk
124042.52
120560.36
124042.52
120560.36
106458.81
b. Formulations
20276.50
9611.45
20276.50
9611.45
15737.57
Total
144319.02
130171.81
144319.02
130171.81
122196.38
* EPS is for the period (not annualised) after providing for taxes.
 
  • The above financial results were taken on record by the Board of Directors at its meeting held on Thursday, January 20, 2005.
  • The above accounts have been subjected to limited review by the Statutory auditors.
  • Figures for the previous periods have been regrouped wherever necessary.
  • The Company received 23 complaints during the quarter ended December 31, 2004 from the shareholders, all the complaints have been resolved and no complaints were pending as on December 31, 2004.

Place : Chennai
Date : January 20, 2005

For and on behalf of the Board

K.Raghavendra Rao
Managing Director